Five Questions about Non-Mevalonate Isoprenoid Biosynthesis
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, most eubacteria utilize the MEP pathway.99”
From Chemistry of the Retinoid (Visual) Cycle (2014) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The function of terpene natural products in the natural world
Gershenzon, J., & Dudareva, N. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.5 · Cited by 2,167 · cited 1×
“, the antimalarial compound artemisinin) [2].”
Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs
Jomaa, H., Wiesner, J., Sanderbrand, S., Altincicek, B., Weidemeyer, C., Hintz, M., Türbachova, I., Eberl, M., Zeidler, J., Lichtenthaler, H. K., et al. (1999) · Science · doi:10.1126/science.285.5433.1573 · Cited by 1,173 · cited 1×
“Fosmidomycin inhibits DXR (the first dedicated step in the MEP pathway) in multiple organisms [9,15,23].”
BackgroundIsoprenoid biosynthesis: The evolution of two ancient and distinct pathways across genomes
Lange, B. M., Rujan, T., Martin, W., & Croteau, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240454797 · Cited by 881 · cited 1×
“The two isoprenoid biosynthetic routes, the mevalonate (MVA) and non-mevalonate (MEP) pathways, have distinct evolutionary origins and are phylogenetically compartmentalized [5,6].”
BackgroundRodrı́guez-Concepción, M., & Boronat, A. (2002) · Plant Physiology · doi:10.1104/pp.007138 · Cited by 857 · cited 1×
“By the early 1990s, however, the existence of an alternative route to IPP had become clear through metabolic labeling studies in bacteria and plants [4].”
BackgroundThe discovery and development of HMG-CoA reductase inhibitors.
Endo, A. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41379-3 · Cited by 847
Connolly, J. D., & Hill, R. A. (1991) · Springer eBooks · doi:10.1007/978-1-4899-4513-6 · Cited by 631 · cited 1×
“Isoprenoids (also referred to as terpenoids) are the largest group of natural products, comprising over 25,000 known compounds [1].”
BackgroundSpecific role of mitochondrial electron transport in blood-stage Plasmodium falciparum
Painter, H. J., Morrisey, J. M., Mather, M. W., & Vaidya, A. B. (2007) · Nature · doi:10.1038/nature05572 · Cited by 512 · cited 1×
“The malaria parasite depends on glycolysis and does not use mitochondrial respiration for ATP production in the intraerythrocytic cycle [17].”
BackgroundThe role of lateral gene transfer in the evolution of isoprenoid biosynthesis pathways
Boucher, Y., & Doolittle, W. F. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02004.x · Cited by 249 · cited 1×
“The two isoprenoid biosynthetic routes, the mevalonate (MVA) and non-mevalonate (MEP) pathways, have distinct evolutionary origins and are phylogenetically compartmentalized [5,6].”
BackgroundSøballe, B., & Poole, R. K. (1999) · Microbiology · doi:10.1099/13500872-145-8-1817 · Cited by 224 · cited 1×
“Ubiquinones and menaquinones are electron carriers and major components of the aerobic and anaerobic respiratory chains, respectively [10].”
BackgroundNair, S. C., Brooks, C. F., Goodman, C. D., Strurm, A., McFadden, G. I., Sundriyal, S., Anglin, J. L., Song, Y., Moreno, S. N. J., & Striepen, B. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110039 · Cited by 156 · cited 2×
“Fosmidomycin inhibits DXR (the first dedicated step in the MEP pathway) in multiple organisms [9,15,23].”
Background
Research works printed but not linked: 1
- Kamiya T Hasimoto M Hemmi K Takeno H Fujisawa Pharmaceutical Company, Limited 1978 Hydroxyaminohydrocarbonphosphonic acids. U.S. Patent No 4206156
Cited by
Chemistry of the Retinoid (Visual) Cycle
Kiser, P. D., Golczak, M., & Palczewski, K. (2014) · Chemical Reviews · doi:10.1021/cr400107q · Cited by 353
Functional Tradeoffs Underpin Salinity-Driven Divergence in Microbial Community Composition
Dupont, C. L., Larsson, J., Yooseph, S., Ininbergs, K., Goll, J., Asplund-Samuelsson, J., McCrow, J. P., Celepli, N., Allen, L. Z., Ekman, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089549 · Cited by 216
“Many of these sub-phyla metabolic changes represent deviations from the predominant metabolic repertoire of each individual phyla based on genomic surveys [29,30].”
BackgroundThousands of previously unknown phages discovered in whole-community human gut metagenomes
Benler, S., Yutin, N., Antipov, D., Rayko, M., Shmakov, S., Gussow, A. B., Pevzner, P., & Koonin, E. V. (2021) · Microbiome · doi:10.1186/s40168-021-01017-w · Cited by 194
Uarrota, V. G., Stefen, D. L. V., Leolato, L. S., Gindri, D. M., & Nerling, D. (2018) · Springer eBooks · doi:10.1007/978-3-319-75088-0_10 · Cited by 171
Bessoff, K., Sateriale, A., Lee, K. K., & Huston, C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02460-12 · Cited by 128
“Isoprenoids are essential precursors for many basic biological functions, including N-glycosylation, protein farnesylation and geranylgeranylation, and the biosynthesis of cholesterol and ubiquinone (32, 33).”
BackgroundDhingra, S., & Cramer, R. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00092 · Cited by 115
“In plants, bacteria and protozoa, a nonmevalonate pathway (NMP) exists for isoprenoid biosynthesis (reviewed in Hunter, 2007; Odom, 2011).”
BackgroundEcological networking of cystic fibrosis lung infections
Quinn, R. A., Whiteson, K., Lim, Y. W., Zhao, J., Conrad, D. J., LiPuma, J. J., Rohwer, F. L., & Widder, S. (2016) · npj Biofilms and Microbiomes · doi:10.1038/s41522-016-0002-1 · Cited by 98
“81 Such precursors can be synthesized into a highly diverse group of compounds including those important for respiration (ubiquinones) and secondary metabolite production.(81) Moreover, the respective isoprenoids are produced by unique enzymes indicating the pathway has the inherent characteristics of a ‘choke point’.”
BackgroundFrom microbial gene essentiality to novel antimicrobial drug targets
Mobegi, F. M., van Hijum, S. A. F. T., Burghout, P., Bootsma, H. J., de Vries, S. P. W., Jongh, C. E. V. D. G., Simonetti, E. R., Langereis, J. D., Hermans, P. W. M., de Jonge, M. I., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-958 · Cited by 80
“Fosmidomycin is a promising isoprenoid-based anti-malarial drug which is currently in clinical trials [48].”
BackgroundA mevalonate bypass system facilitates elucidation of plastid biology in malaria parasites
Swift, R. P., Rajaram, K., Liu, H. B., Dziedzic, A., Jedlicka, A. E., Roberts, A. D., Matthews, K. A., Jhun, H., Bumpus, N. N., Tewari, S. G., et al. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008316 · Cited by 63
“In order to facilitate fundamental research into apicoplast biology, we genetically engi- neered Plasmodium falciparum parasites to express enzymes in the cytosol that belong to an alternate route for isoprenoid synthesis called the mevalonate (MVA) pathway.”
BackgroundInfluentialImlay, L. S., Armstrong, C. M., Masters, M. C., Li, T., Price, K. E., Edwards, R. L., Mann, K. M., Li, L. X., Stallings, C. L., Berry, N. G., et al. (2015) · ACS Infectious Diseases · doi:10.1021/id500047s · Cited by 57
RETRACTED ARTICLE: IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance
Singh, K. S., Sharma, R., Reddy, P. A. N., Vonteddu, P., Good, M., Sundarrajan, A., Choi, H., Muthumani, K., Kossenkov, A. V., Goldman, A. R., et al. (2020) · Nature · doi:10.1038/s41586-020-03074-x · Cited by 60
RetractedGutiérrez-Luna, F. M., Hernández-Domínguez, E. E., Valencia-Turcotte, L. G., & Rodríguez‐Sotres, R. (2017) · Plant Science · doi:10.1016/j.plantsci.2017.10.016 · Cited by 56
Cabral, D. J., Wurster, J. I., Korry, B. J., Penumutchu, S., & Belenky, P. A. (2020) · mSystems · doi:10.1128/msystems.00317-20 · Cited by 48
Armstrong, C. M., Meyers, D. J., Imlay, L. S., Meyers, C. L. F., & John, A. R. O. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00602-15 · Cited by 49
“Because this pathway is absent in humans, MEP pathway enzymes represent an attractive target for antimicrobial development (12, 13).”
BackgroundGuenot, M., Loizon, S., Howard, J., Costa, G., Baker, D. A., Mohabeer, S. Y., Troye‐Blomberg, M., Moreau, J., Déchanet‐Merville, J., Mercereau‐Puijalon, O., et al. (2015) · Infection and Immunity · doi:10.1128/iai.00446-15 · Cited by 43
Price, K. E., Armstrong, C. M., Imlay, L. S., Hodge, D. M., Pidathala, C., Roberts, N. J., Park, J., Mikati, M. O., Sharma, R., Lawrenson, A. S., et al. (2016) · Scientific Reports · doi:10.1038/srep36777 · Cited by 36
Facincani, A. P., Moreira, L. M., Soares, M. R., Ferreira, C. B., Ferreira, R. M., Ferro, M. I. T., Ferro, J. A., Gozzo, F. C., & de Oliveira, J. C. F. (2013) · Functional & Integrative Genomics · doi:10.1007/s10142-013-0340-5 · Cited by 33
“olism and/or in the interaction of Xac with the plant (Odom 2011) because its absence led to a drastic reduction in classical virulence.”
BackgroundNg, S.-M., Lee, X.-W., Isa, M. N. M., Juhari, M. A. A., Adam, J. H., Mohamed, R., Wan, K., & Firdaus‐Raih, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-35173-1 · Cited by 33
Metabolic Survival Adaptations of Plasmodium falciparum Exposed to Sublethal Doses of Fosmidomycin
Tewari, S. G., Rajaram, K., Swift, R., Reifman, J., Prigge, S. T., & Wallqvist, A. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02392-20 · Cited by 29
Amino acid based prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents
Courtens, C., Risseeuw, M., Caljon, G., Maes, L. J. R. M., Martin, A., & Calenbergh, S. V. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.01.016 · Cited by 26
Slade, J. A., Brockett, M. R., Singh, R., Liechti, G. W., & Maurelli, A. T. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008078 · Cited by 25
Cheuka, P. M., Njaria, P. M., Mayoka, G. W., & Funjika, E. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01828 · Cited by 24
Genetic, Biochemical, and Biophysical Methods for Studying Fe S Proteins and Their Assembly
de Choudens, S. O., & Barras, F. (2017) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2017.07.015 · Cited by 21
Misic, A. M., Cain, C. L., Morris, D. O., Rankin, S. C., & Beiting, D. P. (2016) · mSphere · doi:10.1128/msphere.00258-16 · Cited by 19
“Fosmidomycin is extremely well-tolerated and exhibits low toxicity in mammals (32).”
van der Ploeg, G. R., Brandt, B. W., Keijser, B. J. F., van der Veen, M. H., Volgenant, C. M. C., Zaura, E., Smilde, A. K., Westerhuis, J. A., & Heintz‐Buschart, A. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00565-x · Cited by 22
Jeon, Y. C., Nguyen, A. D., & Lee, E. Y. (2019) · Catalysts · doi:10.3390/catal9110883 · Cited by 19
“While archaea and most eukaryotes use the MVA pathway for IPP and DMAPP synthesis, the bacteria (including key pathogens such as all Gram-negative bacteria and mycobacteria) use the MEP pathway [34].”
BackgroundCytidine derivatives as IspF inhibitors of Burkolderia pseudomallei
Zhang, Z., Jakkaraju, S., Blain, J. M., Gogol, K., Zhao, L., Hartley, R. C., Karlsson, C. A., Staker, B. L., Edwards, T. E., Stewart, L. J., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.101 · Cited by 14
Computational screening of natural MtbDXR inhibitors for novel anti-tuberculosis compound discovery
Islam, S., Salekeen, R., & Ashraf, A. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2218933 · Cited by 12
“Isoprenoids, among many other components, are crucial for the survival of all organisms, supporting vital cellular processes like respiration and membrane stability (Odom, 2011).”
BackgroundSass, A. M., Everaert, A., Acker, H. V., den Driessche, F. V., & Coenye, T. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02607-17 · Cited by 13
“This cyclic diphosphate molecule is the precursor of isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) (3, 4).”
BackgroundSechler, A. J., Tancos, M. A., Schneider, D. J., King, J. G., Fennessey, C. M., Schroeder, B. K., Murray, T. D., Luster, D. G., Schneider, W. L., & Rogers, E. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183005 · Cited by 11
Inhibitory Effects of Fosmidomycin Against Babesia microti in vitro
Wang, S., Li, M., Luo, X., Yu, L., Nie, Z., Liu, Q., An, X., Ao, Y., Liu, Q., Chen, J., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00247 · Cited by 9
“IPP in living organisms can be synthesized by two pathways [mevalonate (MVA) pathway and MEP pathway] (Odom, 2011).”
BackgroundFox, D. T., Schmidt, E. N., Tian, H., Dhungana, S., Valentine, M. C., Warrington, N. V., Phillips, P. D., Finney, K. B., Cope, E. K., Leid, J. G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095271 · Cited by 9
“[5–7] While fosmidomycin and its interaction with MEP”
BackgroundKadian, K., Vijay, S., Gupta, Y. A., Rawal, R., Singh, J., Anvikar, A. R., Pande, V., & Sharma, A. (2018) · Parasitology International · doi:10.1016/j.parint.2018.03.001 · Cited by 7
Kim, B. S., Huh, M. D., & Roh, H. (2021) · Current Microbiology · doi:10.1007/s00284-021-02490-0 · Cited by 6
Jamod, H., Mehta, K., Sakariya, A., Shoukani, S., Sanapalli, B. K. R., & Yele, V. (2022) · Assay and Drug Development Technologies · doi:10.1089/adt.2022.038 · Cited by 6
“13 17 Since, IspH is an untapped therapeutic target, explorations are just beginning, and despite the progress made in this area, no single IspH inhibitor is available in the market for therapeutic use.”
Kidane, D. T., Mehari, Y. T., Rice, F. C., Arivett, B. A., Gunderson, J. H., Farone, A. L., & Farone, M. B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278206 · Cited by 5
“The non-mevalonate pathway, common in most gram-negative bacteria, generates the five-carbon isoprenoid precursors isopentyl diphosphate and dimethylallyl diphosphate which can be modified to make diverse organic molecules involved in important biological functions in the cell, including electron transport and peptido…”
BackgroundHaymond, A. N., Dowdy, T., Johny, C., Johnson, C., Ball, H. S., Dailey, A., Schweibenz, B., Villarroel, K., Young, R., Mantooth, C. J., et al. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.11.018 · Cited by 5
“metabolites, of which there are over 25,000 identified, are produced by the condensation of two end products of the MEP pathway, isopentenyl pyrophosphate (IPP, compound 10 in Figure 1) and dimethylallyl pyrophosphate (DMAPP, compound 11) [6].”
Lu, Z., Wang, B., Qiu, Z., Zhang, R., Zheng, J., & Jia, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031560 · Cited by 5
Retraction Note: IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance
Singh, K. S., Sharma, R., Reddy, P. A. N., Vonteddu, P., Good, M., Sundarrajan, A., Choi, H., Muthumani, K., Kossenkov, A. V., Goldman, A. R., et al. (2021) · Nature · doi:10.1038/s41586-021-03961-x · Cited by 5
Khadka, M., Salem, M., & Leblond, J. D. (2015) · Journal of Eukaryotic Microbiology · doi:10.1111/jeu.12237 · Cited by 3
“…photosynthetic capabilities and capacity to synthesize sterols de novo (Labaied et al. 2011), they possess an active MEP pathway (Cassera et al. 2004) that functions in the biosynthesis of various isoprene molecules such as dolichol, carotenoids, ubiquinone, and others (as review by Odom 2011).”
BackgroundWatkins, S. M., Ghose, D., Blain, J. M., Grote, D. L., Luan, C., Clare, M., Meganathan, R., Horn, J. R., & Hagen, T. J. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126660 · Cited by 3
The effect of terpenes on the life cycle of the malaria parasite
Mustapha, O. (2017) · Cited by 2
(Z)-4-Chloro-N-{3-[(4-chlorophenyl)sulfonyl]-2,3-dihydrobenzo[d]thiazol-2-ylidene}benzenesulfonamide
Watkins, S. M., Hagen, T. J., Perkins, T. S., & Zheng, C. (2017) · IUCrData · doi:10.1107/s2414314617008653 · Cited by 1
“The methylerythritolphosphate (MEP) pathway is an essential enzymatic pathway for the biosynthesis of isoprenoid precursors present in most bacteria, some protozoa and plants (Persch et al., 2015; Frank & Groll, 2017; Hunter, 2007; Masini & Hirsch, 2014; Odom, 2011; Hale et al., 2012).”
BackgroundUssin, N. K., Bagnell, A. M., Offermann, L. R., Abdulsalam, R. W., Perdue, M. L., Magee, P., & Chruszcz, M. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.09.008 · Cited by 1
Wang, W., Zhao, F., Li, Q., Lin, Y., Chen, L., & Chen, J. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.736736 · Cited by 1
Howard, J. R. (2015) · theses.fr (ABES) · doi:10.70675/96ed0462z08f7z49bazba1dz8fbfef6c9779 · Cited by 1
Analysis of Anaplasma marginale strains grown in vitro
Lis, K. (2014) · doi:10.35662/unine-thesis-2453 · Cited by 1
Investigating the antimicrobial potential of Thalassomonas actiniarum
Pheiffer, F. (2020) · UWC Research Repository (University of the Western Cape)
Benler, S., Yutin, N., Antipov, D., Rayko, M., Shmakov, S., Gussow, A. B., Pevzner, P. A., & Koonin, E. V. (2021) · Figshare · doi:10.6084/m9.figshare.14337768
Benler, S., Yutin, N., Antipov, D., Rayko, M., Shmakov, S., Gussow, A. B., Pevzner, P. A., & Koonin, E. V. (2021) · Figshare · doi:10.6084/m9.figshare.14337786
Benler, S., Yutin, N., Antipov, D., Rayko, M., Shmakov, S., Gussow, A. B., Pevzner, P. A., & Koonin, E. V. (2021) · Figshare · doi:10.6084/m9.figshare.14337792
Benler, S., Yutin, N., Antipov, D., Rayko, M., Shmakov, S., Gussow, A. B., Pevzner, P. A., & Koonin, E. V. (2021) · Figshare · doi:10.6084/m9.figshare.14337762
Benler, S., Yutin, N., Antipov, D., Rayko, M., Shmakov, S., Gussow, A. B., Pevzner, P. A., & Koonin, E. V. (2021) · Figshare · doi:10.6084/m9.figshare.14337789
Benler, S., Yutin, N., Antipov, D., Rayko, M., Shmakov, S., Gussow, A. B., Pevzner, P. A., & Koonin, E. V. (2021) · Figshare · doi:10.6084/m9.figshare.14337777
Benler, S., Yutin, N., Antipov, D., Rayko, M., Shmakov, S., Gussow, A. B., Pevzner, P. A., & Koonin, E. V. (2021) · Figshare · doi:10.6084/m9.figshare.14337756
Benler, S., Yutin, N., Antipov, D., Rayko, M., Shmakov, S., Gussow, A. B., Pevzner, P. A., & Koonin, E. V. (2021) · Figshare · doi:10.6084/m9.figshare.14337759
Benler, S., Yutin, N., Antipov, D., Rayko, M., Shmakov, S., Gussow, A. B., Pevzner, P. A., & Koonin, E. V. (2021) · Figshare · doi:10.6084/m9.figshare.14337765
Girma, M. B., Dufrisne, M. B., Sehgal, A., Dailey, A., Heidel, K. M., Bague, D. A., Wang, X., Bartholomew, L., Beck, R., Kirby, S. A., et al. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00875
Screening of marine bacteria as a source of bioactive secondary metabolites
Mhlongo, J. K. (2021) · University of the Western Cape Electronic Theses and Dissertations Repository (University of the Western Cape)
BindingDB Entry 50043625: Cytidine derivatives as IspF inhibitors of Burkolderia pseudomallei.
BindingDB (2014) · UC San Diego · doi:10.7270/q2nc62nx
Metadata
- Authors
- Odom, A. R.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-12-22
- Volume
- 7
- Issue
- 12
- Pages
- e1002323
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3245312
- OpenAlex
- W2124339646
- Cited by
- 59
- References
- 24
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 15 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 3 · 2015: 5 · 2014: 4 · 2013: 4
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Children's Discovery Institute
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (K08AI079010)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- methylerythritol phosphate pathway, isoprenoid biosynthesis, terpenoid biosynthesis
- MeSH terms
- Bacteria, Mevalonic Acid, Terpenes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.